DexCom Inc
(BSP:D1EX34)
R$
9.65
0 (0%)
Market Cap: 188.46 Bil
Enterprise Value: 189.06 Bil
PE Ratio: 48.19
PB Ratio: 15.88
GF Score: 74/100 Dexcom Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Dec 01, 2021 / 07:30PM GMT
Release Date Price:
R$15.96
(-1.16%)
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
' -
All right. Good afternoon, everybody. Thank you for joining us. It's Matt O'Brien from Piper's Medtech team. I'm here with you today. We're really pleased to have, to say the least, the DexCom story here. With us today and the company on with us as well from the company is Jereme Sylvain, EVP and Chief Financial Officer.
If you do have questions, we only have about 25 minutes, but if you can enter them at the bottom of the Zoom in the Q&A box or just send me an e-mail at [email protected]. With that preamble out of the way, let's go ahead and get started.
Questions & Answers
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
' -
Jereme, again, thanks so much for the time today.
Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO
Thanks for having us. And look, we greatly appreciate inviting us here
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot